These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9768330)

  • 21. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
    Zhao S; Chen X; Lu X; Yu Y; Feng Y
    Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of differentially expressed microRNAs in endometrial cancer cells after progesterone treatment.
    Bae J; Won M; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH; Suh DS
    Int J Gynecol Cancer; 2012 May; 22(4):561-5. PubMed ID: 22543862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene regulation profiles by progesterone and dexamethasone in human endometrial cancer Ishikawa H cells.
    Davies S; Dai D; Pickett G; Leslie KK
    Gynecol Oncol; 2006 Apr; 101(1):62-70. PubMed ID: 16289307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Up-regulation of p27Kip1 by progestins is involved in the growth suppression of the normal and malignant human endometrial glandular cells.
    Shiozawa T; Horiuchi A; Kato K; Obinata M; Konishi I; Fujii S; Nikaido T
    Endocrinology; 2001 Oct; 142(10):4182-8. PubMed ID: 11564672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone.
    Paulssen RH; Moe B; Grønaas H; Orbo A
    Steroids; 2008 Jan; 73(1):116-28. PubMed ID: 18037150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Regulation of claudin-4 gene expression in endometrial adenocarcinoma Ishikawa cell line by progesterone].
    Jin Y; Feng CP; Wang YN; Lin H; Li HJ; Pan XY
    Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):368-72. PubMed ID: 22883527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
    Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
    Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogens and glucocorticoids induce the expression of c-erbB2/NEU receptor in Ishikawa human endometrial cells.
    Markogiannakis E; Georgoulias V; Margioris AN; Zoumakis E; Stournaras C; Gravanis A
    Life Sci; 1997; 61(11):1083-95. PubMed ID: 9307054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levels of corticosteroid-binding globulin mRNA in human ovarian cancers.
    Misao R; Iwagaki S; Sun WS; Fujimoto J; Tamaya T
    Tumour Biol; 1999; 20(5):263-9. PubMed ID: 10436419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
    Katsuki Y; Shibutani Y; Aoki D; Nozawa S
    Cancer; 1997 Jan; 79(1):169-76. PubMed ID: 8988742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex hormone-binding globulin and corticosteroid-binding globulin mRNA levels in infertile women with luteal phase deficiency.
    Misao R; Nakanishi Y; Fujimoto J; Tamaya T
    Gynecol Endocrinol; 1995 Sep; 9(3):195-200. PubMed ID: 8540288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct functional differences of human progesterone receptors A and B on gene expression and growth regulation in two endometrial carcinoma cell lines.
    Smid-Koopman E; Blok LJ; Kühne LC; Burger CW; Helmerhorst TJ; Brinkmann AO; Huikeshoven FJ
    J Soc Gynecol Investig; 2003 Jan; 10(1):49-57. PubMed ID: 12517594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation.
    Dai D; Kumar NS; Wolf DM; Leslie KK
    Am J Obstet Gynecol; 2001 Apr; 184(5):790-7. PubMed ID: 11303185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiestrogenic compounds inhibit estrogen-induced expressions of basic fibroblast growth factor and its mRNA in well-differentiated endometrial cancer cells.
    Fujimoto J; Hori M; Ichigo S; Hirose R; Tamaya T
    Gen Pharmacol; 1997 Feb; 28(2):215-9. PubMed ID: 9013197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice.
    Hanekamp EE; Kühne LM; Grootegoed JA; Burger CW; Blok LJ
    Endocr Relat Cancer; 2004 Dec; 11(4):831-41. PubMed ID: 15613456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early effects of high concentrations of progesterone and mifepristone A gene expression study of endometrial cancer cells (Ishikawa).
    Ørbo A; Moe BT; Grønaas H; Paulssen RH
    J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):139-49. PubMed ID: 19138738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of insulin-like growth factors and their binding proteins in the estrogen responsive Ishikawa human endometrial cancer cell line.
    Hana V; Murphy LJ
    Endocrinology; 1994 Dec; 135(6):2511-6. PubMed ID: 7527333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
    Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
    Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced c-jun activity alters responsiveness to medroxyprogesterone acetate in Ishikawa human endometrial carcinoma cells.
    Alkhalaf M; Murphy LJ; Murphy LC
    Mol Endocrinol; 1993 Dec; 7(12):1634-41. PubMed ID: 8145769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of keratinocyte growth factor and its receptor in human endometrial cancer in cooperation with steroid hormones.
    Ishikawa A; Kudo M; Nakazawa N; Onda M; Ishiwata T; Takeshita T; Naito Z
    Int J Oncol; 2008 Mar; 32(3):565-74. PubMed ID: 18292933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.